About EMERVAX INC.
Emervax is a biotechnology company focused on developing next-generation vaccines using circRNA technology to address emerging viruses and chronic diseases. The company was founded by leaders in RNA biochemistry and infectious diseases.
Development of next-generation vaccines for emerging viruses and chronic diseasesLeveraging circRNA technology, advanced purification methods, and innovative delivery strategies
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to EMERVAX INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.